Literature DB >> 26577520

Aging as a Precipitating Factor in Chronic Restraint Stress-Induced Tau Aggregation Pathology, and the Protective Effects of Rosmarinic Acid.

Ye Shan, Dan-Dan Wang, Yu-Xia Xu, Chu Wang, Lan Cao, Yun-Sheng Liu, Cui-Qing Zhu.   

Abstract

Stress is an important risk factor of Alzheimer's disease (AD). It has been evidenced that stress could induce tau phosphorylation and increase tau insolubility in brain; however, little is known about the interactional effect of stress with aging on tauopathy. Therefore, we explored the effects of aging on stress-induced tauopathy and the potential mechanism in mouse model of chronic restraint stress (CRS). Here we found that in general, the level of phosphorylated tau (P-tau) was higher in brain of middle-aged mice than that in adult mice under physiological conditions. CRS-induced tau phosphorylation and its insolubility were more prominent in middle-aged mice. The increase of AT8-labeled insoluble P-tau was dramatic in middle-aged mice, which was highly ubiquitinated but did not form PHF structures. The levels of chaperones were relatively lower in middle-aged mice brain; CRS further reduced the expression, especially for HDJ2/HSP40. CRS also suppressed the expression of Pin1, the peptidylprolyl cis/trans isomerase, in middle-aged mice but not in adult mice. Downregulation of HSP40 or Pin1 caused an increase of transfected extraneous tau in 293 cells. Rosmarinic acid (RA) could effectively suppress the elevation of P-tau and insoluble P-tau formation induced by CRS, and reversed the abnormal changes of chaperones and Pin1 particularly in middle-aged mice. Taken together, our findings provided evidence that aging could be a promoting factor in stress-induced tauopathy, which was relevant with malregulation of chaperones and Pin1, and RA might be a promising beneficial agent for stress-induced tauopathy.

Entities:  

Keywords:  Aging; chaperones; chronic restraint stress; insolubility; rosmarinic acid; tau phosphorylation

Mesh:

Substances:

Year:  2016        PMID: 26577520     DOI: 10.3233/JAD-150486

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

1.  Amelioration of oxidative stress and neuroinflammation in lipopolysaccharide-induced memory impairment using Rosmarinic acid in mice.

Authors:  Chetan Thingore; Viplav Kshirsagar; Archana Juvekar
Journal:  Metab Brain Dis       Date:  2020-10-17       Impact factor: 3.584

Review 2.  Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer's and Vascular Dementia Drugs.

Authors:  Solomon Habtemariam
Journal:  Int J Mol Sci       Date:  2018-02-03       Impact factor: 5.923

3.  The anti-inflammatory and anti-glycative effects of rosmarinic acid in the livers of type 1 diabetic mice.

Authors:  Yu-Ju Wen; Mei-Chin Yin
Journal:  Biomedicine (Taipei)       Date:  2017-08-25

Review 4.  The Neuroprotective Effects of Phenolic Acids: Molecular Mechanism of Action.

Authors:  Dominik Szwajgier; Kamila Borowiec; Katarzyna Pustelniak
Journal:  Nutrients       Date:  2017-05-10       Impact factor: 5.717

5.  Memantine Differentially Regulates Tau Phosphorylation Induced by Chronic Restraint Stress of Varying Duration in Mice.

Authors:  Yunsheng Liu; Lan Cao; Xiaoxu Zhang; Yan Liang; Yuxia Xu; Cuiqing Zhu
Journal:  Neural Plast       Date:  2019-02-14       Impact factor: 3.599

6.  An Herbal Formula CGplus Ameliorates Stress-Induced Hepatic Injury in a BALB/c Mouse Model.

Authors:  Hyeong-Geug Kim; Yun-Hee Kim; Sung-Bae Lee; Jin-Seok Lee; Sung-Wook Chae; Dong-Gu Kim; Chang-Gue Son
Journal:  Front Pharmacol       Date:  2020-04-14       Impact factor: 5.810

Review 7.  Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer's Disease.

Authors:  Giuseppe Caruso; Justyna Godos; Anna Privitera; Giuseppe Lanza; Sabrina Castellano; Alessio Chillemi; Oliviero Bruni; Raffaele Ferri; Filippo Caraci; Giuseppe Grosso
Journal:  Nutrients       Date:  2022-02-15       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.